Dr. Juan Camilo Arjona Ferreira - 01 Jan 2024 Form 3 Insider Report for Organon & Co. (OGN)

Role
Head of R&D & CMO
Signature
/s/ Tarnetta Jones, as Attorney-in-fact for Dr. Juan Camilo Arjona Ferreira
Issuer symbol
OGN
Transactions as of
01 Jan 2024
Net transactions value
$0
Form type
3
Filing time
11 Jan 2024, 14:55:18 UTC
Previous filing
10 Mar 2023
Next filing
16 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OGN Common Stock 13 01 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OGN Restricted Stock Units 01 Jan 2024 Common Stock 34,557 Direct F1, F2
holding OGN Restricted Stock Units 01 Jan 2024 Common Stock 19,339 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units vest and are distributed as shares of Organon & Co. common stock in three equal installments of 11,519 shares on each of August 11, 2024; August 11, 2025; and August 11, 2026.
F2 Each restricted stock unit represents a contingent right to receive one share of Organon common stock.
F3 These restricted stock units vest and are distributed as shares of Organon & Co. common stock in three installments: 6,446 shares on November 7 2024; 6,446 shares on November 7, 2025; and 6,447 shares on November 7, 2026.

Remarks:

Exhibit 24-Power of Attorney